Dr. Nahid Abbas
Akshaya Institute of Pharmacy, Shridevi Institute of pharmacy, Rajiv Gandhi University of Health Sciences, Acharya & B M Reddy College of Pharmacy
0000-0002-2877-760X
About
• Accomplished professional with extensive experience in Organic and Medicinal Chemistry Research programs in India and KSA
• Expertise in drug discovery, in-silico drug designing, in-silico screening of small molecules through QSAR technique pharmacophore modelling, synthesis of small molecules, purification characterization, in-vitro, in-vivo cancer studies and discovery of novel leads for various cancers
• Have had successful tenures as Associate Professor, R&D - In charge, with several universities, teaching Chemistry (Analytical, Medicinal, Organic and Inorganic Chemistry), providing guidance to integrated and collaborative research work for students
• In-depth expertise in developing and executing effective research plans, proficient in academic writing, reviewer of scientific publications; won several awards and filed patents
• Possess sound technical knowledge with a passion for learning new concepts, technologies and solutions in the field of research to formulate advanced techniques and have successfully worked with teams to meet project specific requirements, ensuring critical timelines are met
Employment
-
Akshaya Institute of Pharmacy Professor &HOD2023 - Present
-
Shridevi Institute of pharmacy Professor, R &D Head2021 - 2023
-
Acharya & B M Reddy College of Pharmacy2017 - 2021
-
AlQassim University, College of Pharmacy Senior Lecturer2011 - 2017
Education
-
Rajiv Gandhi University of Health Sciences Mpharm2006 - 2008
-
Rajiv Gandhi University of Health Sciences Bpharm1998 - 2001
Projects & Funding
Projects & funding information is unavailable.
Publications (9)
- Synthesis and Characterization of Novel (Substituted‐Phenyl)‐(5‐Methoxy‐2‐Phenyl‐1H‐1,3‐Benzimidazol‐1‐yl) Methanone Derivatives and Evaluation of Anticancer Activity Save
- Current Advancement of Enzymatic Targets for the Mitigation of Neurodegenerative Disorders Save
- Development of Benzimidazole Anticancer Leads for EGFR Inhibition by 3D-QSAR Based Virtual Screening, Molecular Docking, Molecular Simulation and Drug Likeness Study Save
- Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies Save
- Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer Save
- Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer Save
- Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review Save
- Fused and Substituted Pyrimidine Derivatives as Profound Anti-Cancer Agents Save
- Design, Synthesis, In Silico and In Vitro Evaluation of Novel Pyrimidine Derivatives as EGFR Inhibitors Save